Latest
Bought
Yekra Player Yekra is a revolutionary new distribution network for feature films. Bought The hidden story about vaccines, autism, drugs and food… Americas health has been BOUGHT. Your health, your family’s health. Now brought to you by Wall Street… “If you thought they hurt us with the banks, wait till you see what they’re doing…
Read MoreHollywood Actor Targeted for Raising Concerns about Vaccine Safety and Efficacy
Christof Lehmann (nsnbc) : Hollywood actor Rob Schneider got first-hand experience about the fact that corporate capitalism is not democracy and that publicly raising concerns about vaccine safety and efficacy issues results in a swift lesson about the fact that freedom of speech is a right that is mitigated by the fact that one’s livelihood and income may…
Read MoreCanary Party Co-Founder Ginger Taylor’s Op Ed on Why Parents Are Refusing Vaccines
All too often, those attempting to openly discuss the problems and failures of the US National Immunization Program are misrepresented in the media. Such was the case with Canary Party Co-Founder, Ginger Taylor, in a story printed last month on vaccine refusal in her home state of Maine. However, while misrepresentation is common, being given…
Read MoreCongressman Bill Posey Investigates CDC Whistleblower Claims
Last week news broke in the autism community that someone from the upper ranks of the CDC’s vaccine research program had finally come clean and admitted that research being published on the vaccine autism link has not been earnest. He expressed deep regret and guilt at taking part in burying the link between the MMR…
Read MoreRob Schneider Demands Answers on CDC MMR Fraud
In light of the revelation that Dr. William Thompson, senior scientiest at CDC, has admitted guilt in hiding data that found that black males are 340% more likely to have an autism diagnosis when given the MMR before age 3, Rob Schneider has written to the office of the Governor of California, Jerry Brown, to…
Read MoreFDA Lifts Ban on Burzynski
“The Burzynski Research Institute, Inc. (BRI) announced today that U.S. Food and Drug Administration (FDA) has notified the company that its partial clinical hold on its IND for Antineoplastons A10/AS2-1 Injections has been lifted. The FDA has determined that under its IND the Company may initiate its planned Phase 3 study in newly diagnosed diffuse, intrinsic,…
Read More